loadpatents
Patent applications and USPTO patent grants for Yancopoulos; George.The latest application filed is for "genetically modified non-human animals and methods of use thereof".
Patent | Date |
---|---|
Use of a VEGF antagonist to treat angiogenic eye disorders Grant 11,253,572 - Yancopoulos February 22, 2 | 2022-02-22 |
Genetically Modified Non-Human Animals And Methods Of Use Thereof App 20210368752 - Flavell; Richard ;   et al. | 2021-12-02 |
Use Of A Vegf Antagonist To Treat Angiogenic Eye Disorders App 20210308216 - YANCOPOULOS; George | 2021-10-07 |
Use Of A Vegf Antagonist To Treat Angiogenic Eye Disorders App 20210308217 - YANCOPOULOS; George | 2021-10-07 |
Genetically modified non-human animals and methods of use thereof Grant 11,026,408 - Flavell , et al. June 8, 2 | 2021-06-08 |
Dosing Regimens For Treating Or Preventing C5-associated Diseases App 20210139573 - Davis; John ;   et al. | 2021-05-13 |
Use Of A Vegf Antagonist To Treat Angiogenic Eye Disorders App 20210121524 - YANCOPOULOS; George | 2021-04-29 |
Methods of modifying genes in eukaryotic cells Grant 10,988,776 - Economides , et al. April 27, 2 | 2021-04-27 |
Use Of A Vegf Antagonist To Treat Angiogenic Eye Disorders App 20210085753 - YANCOPOULOS; George | 2021-03-25 |
Genetically Modified Non-Human Animals And Methods Of Use Thereof App 20200093105 - Flavell; Richard ;   et al. | 2020-03-26 |
Genetically modified non-human animals and methods of use thereof Grant 10,433,527 - Flavell , et al. O | 2019-10-08 |
Genetically Modified Non-Human Animals And Methods Of Use Thereof App 20190082663 - Flavell; Richard ;   et al. | 2019-03-21 |
Methods Of Modifying Genes In Eukaryotic Cells App 20180371493 - Economides; Aris N. ;   et al. | 2018-12-27 |
Genetically Modified Non-Human Animals And Methods Of Use Thereof App 20180020647 - Flavell; Richard ;   et al. | 2018-01-25 |
Genetically modified non-human animals and methods of use thereof Grant 9,820,476 - Flavell , et al. November 21, 2 | 2017-11-21 |
Anti-Activin A antibodies and uses thereof Grant 9,718,881 - Gromada , et al. August 1, 2 | 2017-08-01 |
Methods, Compositions And Kits For Cell Specific Modulation Of Target Antigens App 20170058045 - GROMADA; Jesper ;   et al. | 2017-03-02 |
Genetically Modified Non-human Animals And Methods Of Use Thereof App 20150208622 - Flavell; Richard ;   et al. | 2015-07-30 |
Methods Of Modifying Genes In Eukaryotic Cells App 20140155689 - Economides; Aris N. ;   et al. | 2014-06-05 |
Method of tumor regression with VEGF inhibitors Grant 7,354,578 - Kandel , et al. April 8, 2 | 2008-04-08 |
Methods of modifying genes in eukaryotic cells App 20070275466 - Economides; Aris N. ;   et al. | 2007-11-29 |
Genome mutation by intron insertion into an embryonic stem cell genome Grant 7,205,148 - Economides , et al. April 17, 2 | 2007-04-17 |
Use of a VEGF antagonist in combination with radiation therapy App 20050196340 - Holash, Jocelyn ;   et al. | 2005-09-08 |
Methods of treating peripheral neuropathies using neurotrophin-3 Grant 6,933,276 - Hohn , et al. August 23, 2 | 2005-08-23 |
Use of a VEGF antagonist in combination with radiation therapy App 20050112061 - Holash, Jocelyn ;   et al. | 2005-05-26 |
Methods of modifying genes in eukaryotic cells App 20050003543 - Economides, Aris N. ;   et al. | 2005-01-06 |
Method of tumor regression with VEGF inhibitors App 20040265309 - Kandel, Jessica ;   et al. | 2004-12-30 |
Brain derived neurotrophic factor Grant 5,438,121 - Barde , et al. * August 1, 1 | 1995-08-01 |
Brain derived neurotrophic factor Grant 5,229,500 - Barde , et al. July 20, 1 | 1993-07-20 |
Brain-derived neurotrophic factor Grant 5,180,820 - Barde , et al. January 19, 1 | 1993-01-19 |
SEC | 0001226690 | YANCOPOULOS GEORGE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.